Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Almac Group Ltd.’s Diagnostics Business Unit today announced the validated results of the ALM AADx assay, a gene expression test that identifies a subgroup of high grade serous ovarian cancer (HGSOC) patients that have a good prognosis following ...
read more
Friday, December 13, 2013
Almac‘s Enzyme Research and Development team have been recognised at The Irish Laboratory Awards by winning “Laboratory Team of the Year.”
read more
Thursday, September 05, 2013
In a dual announcement Almac Discovery Ltd and Queen’s University, Belfast (QUB) have revealed the launch of a formal working partnership between Almac and the Centre for Cancer Research and Cell Biology (CCRCB) at Queen’s, and a significant ...
read more
The Almac Group Ltd, Is pleased to announce plans to make its ALM AADx assay – a gene expression test developed by its Diagnostics Business Unit – available for clinical use in 2015. Further validation of the test in ovarian cancer is on track for ...
read more
Thursday, August 07, 2025
Almirall and Absci Corporation announced the expansion of their ongoing AI Drug Discovery collaboration with Almirall’s selection of a second target aimed at dermatological indications.
read more
Friday, September 25, 2020
Alnylam and Sharp have announced an agreement for the packaging of Alnylam’s approved RNAi therapeutic in European markets.
read more
Orsini Healthcare Specialty Pharmacy announced that it has been selected by Alnylam Pharmaceuticals, Inc to distribute Onpattro (patisiran) lipid complex injection.
read more
Wednesday, March 04, 2020
Alopexx Oncology has entered into an exclusive license agreement with Beijing Shenogen Pharma Group to develop and commercialize DI-Leu16-IL2 in China and other parts of Asia.
read more
Thursday, January 12, 2023
lora Pharmaceuticals announced that its wholly owned subsidiary, Sovereign Pharmaceuticals, LLC, has acquired, through bankruptcy proceedings, substantially all of Monarch PCM, LLC's manufacturing capabilities located in Fort Worth, TX.
read more
Thursday, August 13, 2020
Novel and generics pharma producer OncoGenerix and Alpha Capital have come to an agreement to build a new injectable pharmaceutical factory in the US.
read more
Alpha Genesis, a primate research firm based in Beaufort County, South Carolina, has been awarded a research contract valued in excess of one million dollars after an open competition.
read more
Wednesday, February 10, 2021
Alphageneron has signed an Exclusive License Agreement with Multimmune for its clinical stage autologous NK cell therapy and companion diagnostic platform.
read more
Alphora is pleased to announce that it has added GMP ICP/MS Heavy Metals Testing in-house, to align with the increased regulatory requirements of USP <232> & <233>, which became effective February 1, 2013. API Drug Substances, Drug Products and Excipients will...
read more
Wednesday, November 18, 2015
Alphora is pleased to announce the completion of a new 3,000 sq. ft. analytical laboratory expansion.
read more
Alphora is pleased to announce that it has completed $2M in capital investments, adding two Flow Chemistry platforms
and additional process chemistry and analytical technologies to its toolbox. These additions represent a significant
investment for...
read more